We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+26.72%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.52B
AUM Growth
+$1.41B
Cap. Flow
+$327M
Cap. Flow %
5.01%
Top 10 Hldgs %
29.27%
Holding
172
New
29
Increased
68
Reduced
18
Closed
14

Top Buys

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$137M
2
VITL icon
Vital Farms
VITL
+$64.9M
3
YETI icon
Yeti Holdings
YETI
+$40.8M
4
GTM
ZoomInfo Technologies
GTM
+$36.8M
5
CWEN icon
Clearway Energy Class C
CWEN
+$32.9M

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$84.7M
2
IPHI
INPHI CORPORATION
IPHI
+$51M
3
W icon
Wayfair
W
+$46.2M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$37.1M
5
RCKT icon
Rocket Pharmaceuticals
RCKT
+$35.4M

Sector Composition

Rank Sector Weight
1 Healthcare 42.34%
2 Technology 25.33%
3 Industrials 10.16%
4 Consumer Discretionary 6.65%
5 Communication Services 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEPC icon
76
Brookfield Renewable
BEPC
$6.08B
$27.2M 0.42%
467,400
+39,600
+9% +$1.9M
MPWR icon
77
Monolithic Power Systems
MPWR
$70.1B
$26.7M 0.41%
72,859
+1,884
+3% +$604K
EPIX
78
DELISTED
ESSA Pharma
EPIX
$26.5M 0.41%
2,335,169
– –
XPO icon
79
XPO
XPO
$23.6B
$26.2M 0.4%
636,107
– –
LII icon
80
Lennox International
LII
$14.4B
$26M 0.4%
95,000
– –
KROS icon
81
Keros Therapeutics
KROS
$199M
$24.4M 0.37%
+346,000
New +$21.8M
CCXI
82
DELISTED
ChemoCentryx, Inc.
CCXI
$24M 0.37%
387,000
+90,000
+30% +$5.15M
SHC icon
83
Sotera Health
SHC
$5.09B
$23.9M 0.37%
+870,000
New +$23.4M
GWPH
84
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$23.8M 0.36%
206,000
-230,000
-53% -$25.8M
KALA icon
85
KALA BIO
KALA
$14.1M
$23.4M 0.36%
1,381
– –
RGEN icon
86
Repligen
RGEN
$7.96B
$22.8M 0.35%
119,000
– –
BFLY icon
87
Butterfly Network
BFLY
$1.89B
$22.1M 0.34%
+1,118,000
New +$14.3M
XNCR icon
88
Xencor
XNCR
$1.5B
$22.1M 0.34%
506,000
+206,000
+69% +$8.52M
ETNB
89
DELISTED
89bio
ETNB
$21.2M 0.32%
869,000
+194,000
+29% +$4.96M
ISRG icon
90
Intuitive Surgical
ISRG
$127B
$20.5M 0.31%
75,000
– –
PHAT icon
91
Phathom Pharmaceuticals
PHAT
$708M
$19.9M 0.31%
600,000
+150,000
+33% +$6.08M
MASS icon
92
908 Devices
MASS
$329M
$19M 0.29%
+333,283
New +$19.5M
XLRN
93
DELISTED
Acceleron Pharma
XLRN
$18.3M 0.28%
142,900
– –
TECX
94
Tectonic Therapeutic
TECX
$529M
$18.2M 0.28%
108,776
-50,000
-31% -$8.89M
SGEN
95
DELISTED
Seagen Inc. Common Stock
SGEN
$18M 0.28%
102,500
– –
LW icon
96
Lamb Weston
LW
$7.22B
$16M 0.25%
203,000
– –
XENE icon
97
Xenon Pharmaceuticals
XENE
$6.06B
$15.8M 0.24%
1,030,140
-243,960
-19% -$2.85M
SPRY icon
98
ARS Pharmaceuticals
SPRY
$509M
$15.8M 0.24%
+341,473
New +$11.4M
REGN icon
99
Regeneron Pharmaceuticals
REGN
$78.5B
$14.9M 0.23%
30,900
– –
ORIC icon
100
Oric Pharmaceuticals
ORIC
$1.15B
$14.6M 0.22%
+430,000
New +$12.3M
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Eventide Asset Management held 172 positions worth $6.52B, up 28% from $5.11B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Eventide Asset Management deployed $327M of net new capital in Q4 2020, opening 29 new positions and adding to 68 existing holdings. Its largest new stake was Praxis Precision Medicines: 234,205 shares worth $184M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Wayfair, an estimated $46.2M trimmed.

  • Eventide Asset Management's largest Q4 2020 buy was Praxis Precision Medicines: 234,205 shares worth $184M.
  • Eventide Asset Management added most to ZoomInfo Technologies in Q4 2020, an estimated $36.8M increase.
  • Eventide Asset Management's biggest Q4 2020 reduction was Wayfair, cutting an estimated $46.2M.
  • Eventide Asset Management fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $84.7M.
  • Eventide Asset Management's ten largest holdings make up 29% of its $6.52B portfolio in Q4 2020.
  • Eventide Asset Management opened 29 new positions and closed 14 in Q4 2020.
  • Eventide Asset Management's portfolio value rose 28% quarter-over-quarter to $6.52B.

Based on Eventide Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.